US 7872110
Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
granted A61KA61K2039/505A61P
Quick answer
US patent 7872110 (Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection) held by United Biomedical, Inc. expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Biomedical, Inc.
- Grant date
- Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/18, A61P37/02